Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus
Year: 2011
Type: article
Source: Nature Biotechnology
DOI: 10.1038/nbt.2020
Authors: Ann D Kwong, Robert S Kauffman, Patricia Hurter, Peter Mueller
Institution: Vertex Pharmaceuticals (United States)
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2162287933
